Contact Information:
Dr. Jonathan Thompson
jt23@le.ac.uk
01-162-523-132
University of Leicester



Kredyty mieszkaniowe Kredyty mieszkaniowe

Sprawdź aktualny ranking najlepszych kredytów mieszkaniowych w Polsce - atrakcyjne kredytowanie nieruchomości.

PRESS-NEWS.org - Press Release Distribution
FREE PRESS RELEASES DISTRIBUTION
RSS - Press News Release
Add Press Release

Have researchers found a new treatment for sepsis?

University of Leicester academics discover new receptor that may be instrumental in the body's response to devastating disease


2013-12-03
(Press-News.org) Contact information: Dr. Jonathan Thompson
jt23@le.ac.uk
01-162-523-132
University of Leicester
Have researchers found a new treatment for sepsis? University of Leicester academics discover new receptor that may be instrumental in the body's response to devastating disease Sepsis, or septicaemia, is a devastating disease that is difficult to diagnose early and for which treatment options are limited. The number of deaths from sepsis exceeds those from lung cancer, and from breast and bowel cancer combined.

Sepsis can affect any age group and is the leading cause of death in Intensive Care: it is estimated that 37,000 people die from severe sepsis in the UK each year with annual NHS costs exceeding £1.5billion.

Sepsis has until recently been under-recognised and despite advances in understanding the biological processes involved, there is still no effective treatment beyond supportive therapy.

Professor David Lambert and Dr Jonathan Thompson of the Department of Cardiovascular Sciences at the University of Leicester have published two collaborative research papers indicating that a newly discovered receptor in the body – similar to the receptors for endorphins or for morphine - might be important in the body's response to sepsis, which could be the key to unlocking a new treatment in the future.

This new receptor is called the 'nociceptin receptor' and the natural substance that activates it is called nociceptin.

The body's initial response to sepsis is to produce an intense reaction from the immune system to fight the infection. This first involves activation of white blood cells, stress hormones and other substances, known as 'inflammatory mediators', which cause inflammation.

It has already been found that nociceptin is involved in inflammation; it affects how white blood cells work. This suggests strongly that nociceptin has an important role in the body's response to inflammation and sepsis. Their theory, which they have explored in both research papers, is that nociceptin makes inflammation or sepsis worse; by blocking the nociceptin system, the symptoms of sepsis could be reduced, which could lead to new treatments.

In the first of the two papers Professor Lambert, as part of a collaboration with Dr Zoë Brookes at the University of Sheffield and Dr Girolamo Calo and Dr Remo Guerrini at the University of Ferrara, has shown for the first time using fluorescent chemistry - which was designed in Ferrara - that nociceptin receptors are found on blood vessels with no nerve supply and that in a laboratory model of sepsis, blocking these receptors is protective. This work was funded by British Journal of Anaesthesthia / Royal College of Anaesthetists and Anaesthetic Research Society.

In the second paper, funded by the Association of Anaesthetists of Great Britain and Ireland and British Journal of Anaesthesia / Royal College of Anaesthetists, Dr Thompson and Professor Lambert have discovered that nociceptin levels in the bloodstream are elevated in patients with sepsis in Intensive Care, demonstrating that nociceptin activation might be important in critically ill patients suffering from sepsis.

Sepsis remains a leading cause of admission to Intensive Care Units, with high mortality, costs, and long-term morbidity in those who survive. The incidence of severe sepsis has increased over the last decade, making the discovery of new treatments highly desirable.

Dr Jonathan Thompson said: "Sepsis is a major health problem for the NHS that has often been under-recognised. It can be rapidly fatal, especially if not diagnosed and treated early, because inflammation can spread and affect many different organs in the body.

"Clinicians are making progress in the early recognition and treatment of sepsis, but we have no specific drugs that effectively stop the spread of inflammation, or the biological processes involved. We have found that nociceptin, a chemical similar to endorphins produced in the body, is increased in inflammation and sepsis.

"This suggests that drugs which block the nociceptin receptor could dampen the widespread inflammation that occurs in sepsis, and improve outcome. More work is needed, but these drugs are being developed. If they are effective then we could potentially save many lives."

Professor David Lambert added: "I am particularly excited by these findings as they translate many years of laboratory work into a possible target for this disease."

### The first paper, 'The Nociceptin/Orphanin FQ Receptor Antagonist UFP-101 Reduces Microvascular Inflammation to Lipopolysaccharide In Vivo', can be accessed at the following link: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0074943

The second paper, 'The Nociceptin/Orphanin FQ System Is Modulated in Patients Admitted to ICU with Sepsis and after Cardiopulmonary Bypass', can be accessed at the following link: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0076682

ELSE PRESS RELEASES FROM THIS DATE:

Talk therapy may reverse biological changes in PTSD patients

2013-12-03
Talk therapy may reverse biological changes in PTSD patients A study of biological markers of PTSD in Biological Psychiatry Philadelphia, PA, December 3, 2013 – A new paper published in Biological Psychiatry suggests that cognitive behavioral therapy for posttraumatic ...

Citrus fruit inspires a new energy-absorbing metal structure

2013-12-03
Citrus fruit inspires a new energy-absorbing metal structure Researchers use a naturally occurring structure to design aluminum materials It has been said that nature provides us with everything that we need. A new study appearing in Springer's Journal of Materials Science ...

Researchers turn current sound-localization theories 'on their ear'

2013-12-03
Researchers turn current sound-localization theories 'on their ear' Mass. Eye and Ear scientists challenge the two dominant theories of how people localize sounds BOSTON (Dec. 3, 2013) – The ability to localize the source of sound is important for navigating ...

New thermoelectronic generator

2013-12-03
New thermoelectronic generator Highly efficient new design, described in 'Journal of Renewable and Sustainable Energy,' converts heat and solar energy into electricity WASHINGTON D.C. Dec. 3, 2013 -- Through a process known as thermionic conversion, heat ...

UK review examines gender differences in COPD patients

2013-12-03
UK review examines gender differences in COPD patients LEXINGTON, Ky. (Dec. 3, 2013) — A new study review authored by the University of Kentucky's Dr. David Mannino examines the gender differences in the prevalence, pathophysiology, and clinical presentation of ...

Unlikely collaboration leads to discovery of 'gender-bending' plant

2013-12-03
Unlikely collaboration leads to discovery of 'gender-bending' plant Bucknell professor Chris Martine never expected to be working with his mentor on identifying a new wild eggplant in Australia, especially since Martine's former colleague passed away years ago Bucknell ...

Neurofeedback tunes key brain networks, improving subjective well-being in PTSD

2013-12-03
Neurofeedback tunes key brain networks, improving subjective well-being in PTSD Pioneering research conducted at Western University (London, Canada) points to a promising avenue for the treatment of post-traumatic stress disorder (PTSD): utilising neurofeedback ...

Majority of Americans believe another government shutdown likely in coming months

2013-12-03
Majority of Americans believe another government shutdown likely in coming months Last government shutdown harmful to medical research ALEXANDRIA, Va.—December 3, 2013—Nearly two-thirds (65%) of Americans say it's likely there will be another government shutdown ...

Manufacturing a new gut to treat GI diseases

2013-12-03
Manufacturing a new gut to treat GI diseases Researchers develop way to grow and control maturation of intestinal stem cells, findings pave new ways to treat gastrointestinal disorders Boston, MA – For those living with gastrointestinal ...

Do sports concussions really cause chronic traumatic encephalopathy?

2013-12-03
Do sports concussions really cause chronic traumatic encephalopathy? Study finds little evidence to support link MAYWOOD, Ill. – It's been widely reported that football and other contact sports increase the risk of a debilitating neurological condition called ...

LAST 30 PRESS RELEASES:

How your brain decides blame and punishment -- and how it can be changed

Uniquely human brain region enables punishment decisions

Pinpointing punishment

Chapman University publishes research on attractiveness and mating

E-cigarettes: Special issue from Nicotine & Tobacco Research

Placental problems in early pregnancy associated with 5-fold increased risk of OB & fetal disorders

UT study: Invasive brood parasites a threat to native bird species

Criminals acquire guns through social connections

Restoring ocean health

Report: Cancer remains leading cause of death in US Hispanics

Twin study suggests genetic factors contribute to insomnia in adults

To be fragrant or not: Why do some male hairstreak butterflies lack scent organs?

International team discovers natural defense against HIV

Bolivian biodiversity observatory takes its first steps

Choice of college major influences lifetime earnings more than simply getting a degree

Dominant strain of drug-resistant MRSA decreases in hospitals, but persists in community

Synthetic biology needs robust safety mechanisms before real world application

US defense agencies increase investment in federal synthetic biology research

Robots help to map England's only deep-water Marine Conservation Zone

Mayo researchers identify protein -- may predict who will respond to PD-1 immunotherapy for melanoma

How much water do US fracking operations really use?

New approach to mammograms could improve reliability

The influence of citizen science grows despite some resistance

Unlocking secrets of how fossils form

What happens on the molecular level when smog gets into the lungs?

Using ultrasound to clean medical instruments

Platinum and iron oxide working together get the job done

Tiny silica particles could be used to repair damaged teeth, research shows

A quantum lab for everyone

No way? Charity's logo may influence perception of food in package

[Press-News.org] Have researchers found a new treatment for sepsis?
University of Leicester academics discover new receptor that may be instrumental in the body's response to devastating disease
Press-News.org is a service of DragonFly Company. All Rights Reserved.
Issuers of news releases are solely responsible for the accuracy of their content.